Article
Single application of 2 percent solution clears infection as well as three-day regimen; nonetheless, hyper-, hypopigmentary changes may last for months
Off-Treatment Remission Achieved with Dupilumab for Pediatric AD
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Combination of Abrocitinib and Dupilumab Effectively Treats Pediatric Atopic Dermatitis
The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
SPROUT Trial Highlights Benefits of Apremilast for Pediatric Psoriasis
Research Observe, Classify Adverse Event Profiles for Pediatric Patients Treated With JAK Inhibitors